Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension
Download in electronic PDF format for $75
Abstract: Human insulin, used in the management of diabetes, is commercially available in the form of solutions or suspensions for injection. This study investigated the preparation and characterization of an oral suspension for insulin. The suspension was prepared by adding human insulin to aqueous soy extract and adjusting the pH of the preparation to 4.0. The mean diameters of insulin particles at this pH were measured to be 29.93 and 28.30 micrometers for voume-surface mean and volume-number mean, respectively. After 24 hours of the suspension standing at room temperature, the sedimentation volume reached a constant value of 0.22. The suspension exchibited shear-thinning rheological properties, since its viscosity decreased when the rate of shear was increased. The formulation was stable for about 18 days when stored in the refrigerator (4 degrees C). Compared to a simple solution of insulin stored at a similar acidic pH reported in the literature, the stability of insulin in the suspension has improved over 2000-fold.
Related Keywords:
human insulin, diabetes, oral suspension, aqueous soy extract, pH, proteolytic enzyme inhibitor, inhibition of proteolytic enzymes
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension
Al-Achi Antoine, Parekh Bhavita
|
Nov/Dec 2004
Pg. 492-495
|
Five Compounds for Treating Diabetes-Related Conditions
Meece Jerry
|
May/Jun 2003
Pg. 170-174
|
Complications of Diabetes
Key David M
|
Mar/Apr 2000
Pg. 88-90
|
Diabetes Book Reviews
Reed-Kane Dana
|
Mar/Apr 2000
Pg. 103-104
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay, Williams LaVonn A
|
Mar/Apr 2011
Pg. 124-128
|
Stability of Allopurinol Suspension Compounded from Tablets
Alexander Kenneth S, Davar Nipun, Parker Gordon A
|
Mar/Apr 1997
Pg. 128-131
|
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E, Hover Sara, Carvalho Maria
|
May/Jun 2018
Pg. 196-202
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
|
Mar/Apr 2016
Pg. 167-174
|
Enalapril Maleate 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 221
|
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 494
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
|
Mar/Apr 2014
Pg. 169-174
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
Return to Top |